Sinecatechins Patent Expiration

Sinecatechins is Used for treating genital warts. It was first introduced by Ani Pharmaceuticals Inc in its drug Veregen on Oct 31, 2006.


Sinecatechins Patents

Given below is the list of patents protecting Sinecatechins, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

NEW
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Veregen US7858662 Medicament for the treatment of viral skin and tumour diseases Oct 02, 2026 Ani Pharms
Veregen US9770406 Medicament for the treatment of viral skin and tumour diseases Jul 12, 2025

(Expired)

Ani Pharms
Veregen US10434059 Medicament for the treatment of viral skin and tumour diseases Nov 18, 2022

(Expired)

Ani Pharms
Veregen US5795911 Composition for treating Condyloma acuminata Oct 31, 2020

(Expired)

Ani Pharms
Veregen US5968973 Method for treating hyperplasia Apr 10, 2017

(Expired)

Ani Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Sinecatechins's patents.

Given below is the list recent legal activities going on the following patents of Sinecatechins.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 11 Mar, 2025 US9770406
Mail O.P. Petition Decision 27 Sep, 2024 US7858662
Mail-Petition Decision - Accept Late Payment of Maintenance Fees - Granted 24 Sep, 2024 US7858662
Petition Decision - Accept Late Payment of Maintenance Fees - Granted 24 Sep, 2024 US7858662
O.P. Petition Decision 23 Sep, 2024 US7858662
Email Notification 10 Sep, 2024 US9770406
Change in Power of Attorney (May Include Associate POA) 10 Sep, 2024 US9770406
Change in Power of Attorney (May Include Associate POA) 09 Sep, 2024 US7858662
Email Notification 09 Sep, 2024 US7858662
Petition to Accept Late Payment of Maintenance Fee Payment Filed 08 Aug, 2024 US7858662


Sinecatechins's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sinecatechins Generic API Manufacturers

Given below is the list of companies who have filed for Sinecatechins generic, along with the locations of their manufacturing plants worldwide.